Close
Loading...
CONTACT US
:
:
:
Call us at:
:
:
:
Fax:
Email:

MYRF

Products

Loading...

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Background

Myelin regulatory factor (MYRF) is a fascinating membrane-bound transcriptional regulator that occupies an essential non-redundant position in oligodendrocyte differentiation and central nervous system (CNS) myelination. To free its N-terminal transcription factor domain for nuclear entry and gene activation, it requires an unusual autoproteolytic self-cleavage event. This parasite activation mechanism, which has a molecular evolutionary basis via an intramolecular chaperone auto-processing (ICA) domain homologous to bacteriophage tail spike proteins and is the first such domain described for eukaryotic protein function, may also underlie MYRF's distinction from all other known mammalian transcription factors. MYRF is most abundantly expressed in oligodendrocytes but it also shows distinct expression patterns in other cell types, such as the retinal pigment epithelium (RPE), where MYRF function is necessary for normal eye development and coelomic epithelium-derived cells that give rise to certain visceral organs during organogenesis. This association has expanded to a wider spectrum of heterozygous pathogenic variants in MYRF implicated in human disease, including nanophthalmos, cardiac-urogenital-diaphragm-lung (CUDL) syndrome comprising congenital heart defects and pulmonary hypoplasia, as well as the recently characterized neurological disorder known as MYRF-related mild encephalopathy with reversible myelin vacuolization (MMERV). Adverse traits conferred by MYRF mutations capture a balance of its ubiquitous biologic activities and the variation among developmental processes in their sensitivity to gene dosage perturbations.

Fig.1. MYRF auto-cleavage. (OA Literature)Fig.1 The schematic of Myrf auto-cleavage.1

MYRF Protein Function: A Hub of Cellular Regulation

MYRF's functional repertoire encompasses several facets of neural development, myelin biology and disease pathogenesis:

  • Oligodendrocyte Terminal Differentiation and Myelination: MYRF is a key transcriptional regulator controlling lineage-specific terminal differentiation of oligodendrocytes from oligodendrocyte precursor cells (OPCs) into mature, myelin-producing cells. MYRF conditional ablation in the mouse CNS causes severe defects in myelination, with premyelinating oligodendrocytes stalling at an immature stage and failing to express major myelin genes such as Mbp, Plp1, Mag, and Mog. Chromatin immunoprecipitation sequencing (ChIP-Seq) analyses have identified numerous MYRF-binding sites across the oligodendrocyte genome, with enrichment near genes involved in myelin structure, lipid synthesis, and cytoskeletal regulation required for membrane wrapping.
  • Remyelination and Adult Myelin Repair: Beyond its developmental role, MYRF plays a critical requirement for remyelination during demyelenating injury in adult CNS. Conditional inactivation of MYRF specifically in adult OPCs using two separate cuprizone-induced demyelination models completely inhibits the generation of oligodendrocytes, abolishes remmyelination and leaves Demoed axons permanently denuded (of myelin), unable to resist degeneration. In contrast, forced overexpression of MYRF in cultured OPCs can not only bypass this blockade to induce differentiation but also robustly activate myelin gene expression even under otherwise non-permissive conditions.
  • Negative Regulation by TMEM98: ER membrane-bound transmembrane protein that interacts with the C-terminal domain of MYRF and inhibits self-cleavage for nuclear transport. TMEM98 is specifically expressed in oligodendrocytes that are at an early stage of maturation and its ectopic expression inhibited both the initiation of endogenous differentiation as well as induction myelin gene expression by MYRF. This TMEM98-MYRF association is the first mechanism associated with MYRF activation control, and presents a molecular brake likely to stop early or excessive myelination during development.

MYRF Membrane Protein Product

A high-quality and updated selection of MYRF protein products crucial for structural and functional studies on this demanding membrane-bound transcription factor. MYRF can be expressed in different expression systems using our proprietary recombinant protein technology. Realising that full-length MYRF is a large type II transmembrane protein, which requires correct ER insertion for authentic autoproteolytic processing, our portfolio nicely covers the requirement of structure; we have produced not only full length MYRF but also N-MYRF -the released transcription factor fragment after self-cleavage and DBD-dedicated to structural studies in addition to the ICA domain, mainly directed towards cleavage mechanism study. Formats available include detergent-solubilized full-length preparations, soluble N-MYRF fragments with native trimeric assembly and a range of tag combinations for domain constructs (His-tag, FLAG-tag, GST-tag or StrepTag). We provide co-expression and/or co-purification of this heteromeric complex for researchers studying the TMEM98-MYRF regulatory interaction. For your application needs, each batch is tested at the standard level by various quality control methods including SDS-PAGE, Western blot analysis, SEC-HPLC, DNA-binding EMSA and functional transcriptional activation assays.

MYRF Protein Product

Not finding the membrane protein product you need? Contact us to start your one-stop custom service!

MYRF Stable Cell Line Product

We offer a new resource of purposefully engineered MYRF stable cell lines with high-level and reproducible expression across the range of potential forms-of-action target constructs. These stable cell lines are well-suited for drug screening, myelin gene reporter assays, and high-throughput screening campaigns. The cell line development platform can be used in various host backgrounds such as HEK293, CHO-K1 and the CG-4 rat oligodendrocyte progenitor cell line with either an inducible or constitutive expression system. Using these vectors we have produced inducible lines with ON (i.e., MYRF-expression) or OFF-MYRF expression for lineage tracing and functional studies, as well knockdown via dominant-negative MYRF constructs for loss-of-function analyses along with the introduction of integrated whole-cell myelin transcriptional gene reporter constructs such MBP-luciferase or PLP1-GFP. The homogenous and stable expression of these transgene cell lines with functional myelin gene induction assays is validated by flow cytometry, Western blotting, and immunofluorescence localization assay.

MYRF Stable Cell Line Product

Not finding the stable cell line product you need? Contact us to start your one-stop custom service!

MYRF Recombinant Antibody Product

We provide a comprehensive suite of high-affinity recombinant antibodies targeting MYRF that are engineered for robust performance across applications. Using cutting-edge recombinant technologies, these antibodies are more specific, sensitive and demonstrate better batch-to-batch reproducibility than hybridoma-derived monoclonal antibodies. Our anti-MYRF antibodies are generated against specific epitopes spread across the N-terminal Pro domain, DBD, ICA domain and transmembrane region/C-terminal domains to achieve rigorous detection of both full-length 125 kDa ER-associated protein as well as the 75-kDa N-MYRF cleavage product. This data sheet lists all validated applications including Western blot (detected both full-length and cleaved forms in oligodendrocyte lysates), immunohistochemistry (IHC) of brain/spinal cord tissue sections, immunofluorescence IF for subcellular localization studies ER nuclear flow cytometry ELISA. They are available in both monoclonal and polyclonal versions, conjugated to fluorescent dyes (PE, FITC, Alexa Fluor), enzymes (HRP or AP) or biotin for your custom experimental processes. In addition to specificity, our matched antibody pairs also demonstrate effective quantitative detection of MYRF in complex biological samples such as cerebrospinal fluid and serum.

MYRF Recombinant Antibody Product

Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!

Product Features

  • High Purity & Activity: High purity and verified integrity for dependable downstream work.
  • Diverse Expression Systems: Choice of expression formats to match routine or specialized projects.
  • Species Reactivity: Products available for human, mouse, pig, and other species.
  • Validated Applications: Application-tested to deliver consistent signals across common lab workflows.
  • Superior Batch-to-Batch Consistency: Stringent quality controls to ensure low variability from batch to batch.
  • Customization Options: Tags/Labels/package Modifications available upon request.

Custom MYRF Membrane Protein and Antibody Discovery Services

In addition to our catalog products, we provide specialized custom services for membrane protein and antibody discovery & development. Using our deep expertise and world-class platforms, we can help you with:

  • Production & Validation: Cloning of the synthesized optimized gene into an expression vector, plus small-scale expression trials to help determine the best expression conditions.
  • Custom Antibody Production: Produced via large-scale expression in mammalian/insect/cell culture or bacterial expression systems, purified in detergent or reconstituted into nanodiscs.
  • Engineered Cell Lines: Creation of stable cell lines that physiologically mimic endogenous MYRF expression and activity.
  • Functional Assessment Systems: Designing and executing assays to assess protein function and ligand binding.

Frequently Asked Questions (FAQ)

  1. Are your MYRF products suitable for clinical use?

    No. All MYRF products and services are intended for research use only and are not intended for diagnostic, therapeutic, or other clinical applications.

  2. What types of MYRF products do you offer?

    We offer a range of products including recombinant MYRF proteins (full-length, N-MYRF cleavage product, DBD, and ICA domain constructs), stable cell lines expressing wild-type and mutant MYRF, and high-quality recombinant anti-MYRF antibodies, along with comprehensive custom services.

  3. Do you offer stable cell lines with tetracycline-inducible MYRF expression for temporal modeling of oligodendrocyte differentiation, myelin gene activation, and precursor-to-mature cell transition kinetics?

    Yes, we have constructed stable lines in which MYRF transcription is placed under a tetracycline-responsive promoter. This arrangement permits precise initiation of expression at defined time points and subsequent monitoring of progressive myelin basic protein induction, proteolipid protein promoter occupancy, and membrane sheet extension with temporal resolution, eliminating the asynchronous differentiation inherent to constitutive overexpression systems.

  4. What expression systems are recommended for MYRF protein production?

    Mammalian expression systems (HEK293, CHO) are recommended for full-length MYRF to ensure proper ER insertion, transmembrane domain folding, and authentic autoproteolytic processing. Insect cell systems are also suitable. Bacterial expression is feasible for individual soluble domains (DBD, ICA) but cannot support full-length protein production or cleavage. Co-expression with TMEM98 is available for studying the regulatory complex.

Reference
  1. An, Hongjoo, et al. "Functional mechanism and pathogenic potential of MYRF ICA domain mutations implicated in birth defects." Scientific reports 10.1 (2020): 814. Under Open Access license CC BY 4.0, without modification. https://doi.org/10.1038/s41598-020-57593-8
Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us
Thanksgiving Sale - up to 20% off membrane proteins and stable cell lines
Membrane Proteins Stable Cell Lines
;